Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia and Tumor Angiogenesis in the Era of Hepatocellular Carcinoma Transarterial Loco-Regional Treatments
Mario Petrillo, Francesca Patella, Filippo Pesapane, et al.
Future Oncology (2018) Vol. 14, Iss. 28, pp. 2957-2967
Closed Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
Yutian Chen, Yangfan Zhou, Peipei Li, et al.
Deleted Journal (2025) Vol. 2, Iss. 2, pp. 100070-100070
Closed Access
Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study
Jing Li, Yaowei Bai, Fu Xiong, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 973-984
Open Access
Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
Huiying Gu, Jing Li, Nan You, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 24, pp. 1677-1677
Open Access | Times Cited: 24
CaCO3‐Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma
Aimi Zhang, Zhisheng Xiao, Qiufang Liu, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 19
Closed Access | Times Cited: 23
A Study on Overcoming Post‐TACE Drug Resistance in HCC Based on Controllable Oxygen Release‐Magnetic Hyperthermia Therapy
Jinxin Huang, Weihua Zhang, Ye‐Ming Wu, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5797-5797
Open Access | Times Cited: 18
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
Leonard Kaps, María J. Limeres, Paul M. Schneider, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11869-11869
Open Access | Times Cited: 7
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
Zizhuo Wang, Qing Li, Bin Liang
(2024)
Open Access | Times Cited: 2
Fullerene Derivatives for Tumor Treatment: Mechanisms and Application
Wenjia Hou, Lan Shen, Yimin Zhu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9771-9797
Open Access | Times Cited: 2
Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression
Song Li, Chunyan Zhu, Qing Shi, et al.
EBioMedicine (2024) Vol. 109, pp. 105436-105436
Open Access | Times Cited: 2
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
Zhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 4, pp. 283-283
Open Access | Times Cited: 15
The effect of stem cells and vascular endothelial growth factor on cancer angiogenesis
Nahid Moradi-Gharibvand, Batool Hashemibeni
Advanced Biomedical Research (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma
Qiangnu Zhang, Lijun Qiao, Quan Liu, et al.
Aging (2021) Vol. 13, Iss. 5, pp. 6525-6553
Open Access | Times Cited: 13
Role of secretory clusterin in hepatocarcinogenesis
Min Yao, Miao Fang, Wenjie Zheng, et al.
Translational Gastroenterology and Hepatology (2018) Vol. 3, pp. 48-48
Open Access | Times Cited: 16
Low Inorganic Phosphate Stress Inhibits Liver Cancer Progression: from In Vivo to In Vitro
Qiu‐Chen Bi, Rong-guang Luo, Yanshu Li, et al.
Advanced Therapeutics (2021) Vol. 5, Iss. 2
Closed Access | Times Cited: 11
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Ningjie Li, Jiao Chen
Irish Journal of Medical Science (1971 -) (2022) Vol. 191, Iss. 6, pp. 2611-2617
Open Access | Times Cited: 8
Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin
Yangfeng Lv, Zhi-Qiang Deng, Qiu‐Chen Bi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1743-1753
Open Access | Times Cited: 8
Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures
Chiara Floridi, Michaela Cellina, Giovanni Irmici, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4028-4028
Open Access | Times Cited: 8
Gas generating microspheres for immediate release of Hsp90 inhibitor aiming at postembolization hypoxia in transarterial chemoembolization therapy of hepatocellular carcinoma
Jin Woo Choi, Song Yi Lee, Eun Ju Cho, et al.
International Journal of Pharmaceutics (2021) Vol. 607, pp. 120988-120988
Closed Access | Times Cited: 10
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study
Haohao Lu, Chuansheng Zheng, Bin Liang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study
Huiwen Yan, Xinhui Wang, Lihua Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
Zizhuo Wang, Qing Li, Bin Liang
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1057-1057
Open Access | Times Cited: 1
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma
Junling Yang, Jie Yang, Rong-Fei Fang, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 12, pp. 1480-1492
Closed Access | Times Cited: 1
Efficacy and safety of atezolizumab combined with bevacizumab, arterial chemoembolization, and hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma: a meta-analysis
Xinlin Yu, Ran Cui, Yan Jiang, et al.
International Journal of Clinical and Experimental Pathology (2024) Vol. 17, Iss. 12, pp. 444-457
Closed Access | Times Cited: 1
Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma
Andrea Cortés, Hideyuki Nishiofuku, Urszula Polak, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 39, pp. 102465-102465
Open Access | Times Cited: 9

Scroll to top